Herbert Irving Comprehensive Cancer Center of Columbia University — New York, New York

Herbert Irving Comprehensive Cancer Center of Columbia University is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Herbert Irving Comprehensive Cancer Center of Columbia University has participated in 1 clinical trials.

Therapeutic areas: Metastatic Pancreatic Cancer.

Sponsors: Aduro Biotech, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Herbert Irving Comprehensive Cancer Center of Columbia University?

Herbert Irving Comprehensive Cancer Center of Columbia University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Herbert Irving Comprehensive Cancer Center of Columbia University conducted?

Herbert Irving Comprehensive Cancer Center of Columbia University has 1 clinical trials on record. Their work covers Metastatic Pancreatic Cancer.

Is Herbert Irving Comprehensive Cancer Center of Columbia University accredited by Crixeo Health?

Herbert Irving Comprehensive Cancer Center of Columbia University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Herbert Irving Comprehensive Cancer Center of Columbia University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.